Found: 2
Select item for more details and to access through your institution.
Trilobatin as an HIV‐1 entry inhibitor targeting the HIV‐1 Gp41 envelope.
- Published in:
- FEBS Letters, 2018, v. 592, n. 13, p. 2361, doi. 10.1002/1873-3468.13113
- By:
- Publication type:
- Article
Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity.
- Published in:
- Retrovirology, 2018, v. 15, n. 1, p. N.PAG, doi. 10.1186/s12977-018-0432-3
- By:
- Publication type:
- Article